Janux Therapeutics, Inc. (JANX) vs Nuvalent, Inc. (NUVL)
Detailed comparison between Janux Therapeutics, Inc., Nuvalent, Inc..Total Return (%)
Janux Therapeutics, Inc. (JANX)Nuvalent, Inc. (NUVL)
Which stock do you think will perform better?
Janux Therapeutics, Inc.
JANX
Nuvalent, Inc.
NUVL
| Metric | Janux Therapeutics, Inc. (JANX) | Nuvalent, Inc. (NUVL) |
|---|---|---|
| Current Price | $28.86 | $108.19 |
| Change | 0.27 (0.94%) | 0.18 (0.17%) |
| Market Cap | $1.74B | $7.87B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -18.04 | -25.52 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $71.71 | $112.53 |
| 52-Week Low | $21.73 | $55.53 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.67 | $-5.33 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| JANX | 9.56% | -28.18% | -42.64% | 14.74% | 14.74% | 14.74% |
| NUVL | 19.05% | 33.04% | 13.97% | 477.01% | 477.01% | 477.01% |